Date | Time | Source | Headline | Symbol | Company |
05/16/2024 | 11:55AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:PFE | Pfizer Inc |
05/16/2024 | 11:55AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:PFE | Pfizer Inc |
05/16/2024 | 7:27AM | IH Market News | Chubb Stock Soars 9% with Berkshire Acquisition, AST SpaceMobile jumps 37% on AT&T deal, and More News | NYSE:PFE | Pfizer Inc |
05/16/2024 | 6:00AM | GlobeNewswire Inc. | Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) | NYSE:PFE | Pfizer Inc |
05/13/2024 | 8:00AM | PR Newswire (US) | Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting | NYSE:PFE | Pfizer Inc |
05/13/2024 | 7:16AM | IH Market News | Arm Sets 2025 Target for AI Chip Development, Amazon and Microsoft Commit Billions to French Investments, and More | NYSE:PFE | Pfizer Inc |
05/09/2024 | 9:01AM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NYSE:PFE | Pfizer Inc |
05/09/2024 | 7:53AM | IH Market News | Bain Capital in Talks to Acquire PowerSchool; Blackstone Emerges Victorious in Hipgnosis Bidding War, and More News | NYSE:PFE | Pfizer Inc |
05/08/2024 | 3:56PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NYSE:PFE | Pfizer Inc |
05/06/2024 | 6:45AM | Business Wire | Pfizer Announces New Chief Strategy and Innovation Officer | NYSE:PFE | Pfizer Inc |
05/01/2024 | 9:12AM | IH Market News | CVS Health, Starbucks, Shares Weaker; Pinterest Soars | NYSE:PFE | Pfizer Inc |
05/01/2024 | 6:45AM | Business Wire | Pfizer Reports First-Quarter 2024 Results | NYSE:PFE | Pfizer Inc |
04/29/2024 | 6:40PM | Business Wire | TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer | NYSE:PFE | Pfizer Inc |
04/29/2024 | 6:40PM | Business Wire | FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer | NYSE:PFE | Pfizer Inc |
04/29/2024 | 6:45AM | Business Wire | Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting | NYSE:PFE | Pfizer Inc |
04/26/2024 | 7:48AM | IH Market News | Anglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More News | NYSE:PFE | Pfizer Inc |
04/26/2024 | 6:45AM | Business Wire | U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B | NYSE:PFE | Pfizer Inc |
04/24/2024 | 4:37PM | Business Wire | Pfizer Declares Second-Quarter 2024 Dividend | NYSE:PFE | Pfizer Inc |
04/24/2024 | 7:28AM | IH Market News | Coca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More News | NYSE:PFE | Pfizer Inc |
04/22/2024 | 8:08AM | Business Wire | European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options | NYSE:PFE | Pfizer Inc |
04/11/2024 | 10:00AM | Business Wire | Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25 | NYSE:PFE | Pfizer Inc |
04/10/2024 | 7:13AM | IH Market News | Delta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More News | NYSE:PFE | Pfizer Inc |
04/09/2024 | 6:45AM | Business Wire | Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease | NYSE:PFE | Pfizer Inc |
04/08/2024 | 12:44PM | PR Newswire (US) | ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager | NYSE:PFE | Pfizer Inc |
03/26/2024 | 7:20AM | IH Market News | Super Micro Computer and Seagate Shares Surge on Analyst Optimism in Pre-Market Trading, and Latest News | NYSE:PFE | Pfizer Inc |
03/21/2024 | 7:17AM | IH Market News | Apple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market Updates | NYSE:PFE | Pfizer Inc |
03/20/2024 | 10:00AM | Business Wire | Pfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with Analysts | NYSE:PFE | Pfizer Inc |
03/19/2024 | 7:33AM | IH Market News | Unilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and More | NYSE:PFE | Pfizer Inc |
03/18/2024 | 7:10AM | IH Market News | Apple & Google in Talks for Gemini AI on iPhone, Nvidia’s GTC Conference Today, and Latest News | NYSE:PFE | Pfizer Inc |
03/13/2024 | 4:00AM | Business Wire | European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease | NYSE:PFE | Pfizer Inc |